Provectus Biopharmaceuticals (PVCT, $0.18) was a top weekly loser, falling -1 to $0.18 per share. Of the 912 stocks analyzed in the Biotechnology Industry throughout the week of April 29 - May 6, of them (6) exhibited an Uptrend while of them (3) were in a Downtrend.